CLEMENTIA PHARMACEUTICALS IN's ticker is CMTA and the CUSIP is 185575107. A total of 31 filers reported holding CLEMENTIA PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $21,817,000 | -31.9% | 835,918 | -69.3% | 0.01% | -37.5% |
| Q4 2018 | $32,051,000 | +9.6% | 2,725,480 | +4.0% | 0.01% | +33.3% |
| Q3 2018 | $29,233,000 | -15.4% | 2,621,799 | -0.1% | 0.01% | -25.0% |
| Q2 2018 | $34,548,000 | -15.0% | 2,625,189 | -2.1% | 0.01% | -11.1% |
| Q1 2018 | $40,627,000 | +4.3% | 2,681,687 | +30.7% | 0.01% | 0.0% |
| Q4 2017 | $38,951,000 | +177.3% | 2,052,272 | +146.8% | 0.01% | +200.0% |
| Q3 2017 | $14,045,000 | – | 831,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 222,000 | $2,611,000 | 2.47% |
| Orbimed Advisors | 10,425,225 | $122,601,000 | 2.27% |
| NEA Management Company, LLC | 2,707,734 | $31,843,000 | 1.26% |
| Perceptive Advisors | 1,500,000 | $17,640,000 | 0.67% |
| Opaleye Management Inc. | 150,000 | $1,764,000 | 0.66% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,008,001 | $11,854,000 | 0.51% |
| Artal Group S.A. | 850,000 | $9,996,000 | 0.37% |
| Baker Brothers Advisors | 3,724,445 | $43,799,000 | 0.36% |
| PFM Health Sciences, LP | 849,904 | $9,995,000 | 0.27% |
| Fosun International Ltd | 234,526 | $2,627,000 | 0.16% |